Cargando…
Serine-Arginine Protein Kinase 1 (SRPK1) as a Prognostic Factor and Potential Therapeutic Target in Cancer: Current Evidence and Future Perspectives
Cancer, a heterogeneous disease composed of tumor cells and microenvironment, is driven by deregulated processes such as increased proliferation, invasion, metastasis, angiogenesis, and evasion of apoptosis. Alternative splicing, a mechanism led by splicing factors, is implicated in carcinogenesis b...
Autores principales: | Nikas, Ilias P., Themistocleous, Sophie C., Paschou, Stavroula A., Tsamis, Konstantinos I., Ryu, Han Suk |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7017105/ https://www.ncbi.nlm.nih.gov/pubmed/31861708 http://dx.doi.org/10.3390/cells9010019 |
Ejemplares similares
-
Serine-arginine protein kinase 1 (SRPK1) is elevated in gastric cancer and plays oncogenic functions
por: Xu, Xiaotao, et al.
Publicado: (2017) -
Serine-Arginine Protein Kinase 1 (SRPK1): a systematic review of its multimodal role in oncogenesis
por: Duggan, William P., et al.
Publicado: (2022) -
Impaired expression of serine/arginine protein kinase 2 (SRPK2) affects melanoma progression
por: Caetano, Mônica Maria Magalhães, et al.
Publicado: (2022) -
SERINE ARGININE PROTEIN KINASE-1 (SRPK1) INHIBITION AS A POTENTIAL NOVEL TARGETED THERAPEUTIC STRATEGY IN PROSTATE CANCER
por: Mavrou, Athina, et al.
Publicado: (2014) -
Serine-arginine protein kinase 1 (SRPK1), a determinant of angiogenesis, is upregulated in prostate cancer and correlates with disease stage and invasion
por: Bullock, Nicholas, et al.
Publicado: (2016)